| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NITROGLYCERIN | 217879 | 001 | ANDA | NITROGLYCERIN | TABLET;SUBLINGUAL | 0.3MG | No | No | 2023/10/26 | 2023/10/26 | AUROBINDO PHARMA | Prescription |
| NITROGLYCERIN | 217879 | 002 | ANDA | NITROGLYCERIN | TABLET;SUBLINGUAL | 0.4MG | No | No | 2023/10/26 | 2023/10/26 | AUROBINDO PHARMA | Prescription |
| NITROGLYCERIN | 217879 | 003 | ANDA | NITROGLYCERIN | TABLET;SUBLINGUAL | 0.6MG | No | No | 2023/10/26 | 2023/10/26 | AUROBINDO PHARMA | Prescription |
| NITROGLYCERIN | 217970 | 001 | ANDA | NITROGLYCERIN | TABLET;SUBLINGUAL | 0.3MG | No | No | 2023/12/05 | 2023/12/05 | MANKIND PHARMA | Prescription |
| NITROGLYCERIN | 217970 | 002 | ANDA | NITROGLYCERIN | TABLET;SUBLINGUAL | 0.4MG | No | No | 2023/12/05 | 2023/12/05 | MANKIND PHARMA | Prescription |
| NITROGLYCERIN | 217970 | 003 | ANDA | NITROGLYCERIN | TABLET;SUBLINGUAL | 0.6MG | No | No | 2023/12/05 | 2023/12/05 | MANKIND PHARMA | Prescription |
| NITROGLYCERIN | 216103 | 001 | ANDA | NITROGLYCERIN | OINTMENT;INTRA-ANAL | 0.4% | No | No | 2024/02/16 | 2024/02/16 | COSETTE | Prescription |
| NITROGLYCERIN | 218583 | 001 | ANDA | NITROGLYCERIN | TABLET;SUBLINGUAL | 0.3MG | No | No | 2024/10/15 | 2024/10/15 | VIWIT PHARM | Prescription |
| NITROGLYCERIN | 218583 | 002 | ANDA | NITROGLYCERIN | TABLET;SUBLINGUAL | 0.4MG | No | No | 2024/10/15 | 2024/10/15 | VIWIT PHARM | Prescription |
| NITROGLYCERIN | 218583 | 003 | ANDA | NITROGLYCERIN | TABLET;SUBLINGUAL | 0.6MG | No | No | 2024/10/15 | 2024/10/15 | VIWIT PHARM | Prescription |